Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria Vaccines”

255 trials

Showing 20 of 255 results

Early research (Phase 1)Active Not RecruitingNCT06735209
What this trial is testing

First-in-Human PfSPZ-LARC2 Vaccination/CHMI

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 22
Post-approval studies (Phase 4)Looking for participantsNCT06068530
What this trial is testing

Mass Vaccine and Drug Administration, Bangladesh

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 10,000
Testing effectiveness (Phase 2)Study completedNCT00289185
What this trial is testing

Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 340
Early research (Phase 1)Study completedNCT00295581
What this trial is testing

PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria

Who this might be right for
Plasmodium FalciparumPlasmodium Vivax Malaria
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00890019
What this trial is testing

AdCh63 ME-TRAP Alone and With MVA ME-TRAP

Who this might be right for
Malaria
University of Oxford 54
Large-scale testing (Phase 3)Looking for participantsNCT06578572
What this trial is testing

Seasonal R21 Mass Vaccination for Malaria Elimination

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 16,200
Testing effectiveness (Phase 2)Study completedNCT03707353
What this trial is testing

An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAP

Who this might be right for
Malaria
University of Oxford 43
Testing effectiveness (Phase 2)Study completedNCT03896724
What this trial is testing

Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso

Who this might be right for
Malaria,Falciparum
University of Oxford 450
Testing effectiveness (Phase 2)Study completedNCT01157897
What this trial is testing

Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve Adults

Who this might be right for
MalariaPlasmodium Vivax
U.S. Army Medical Research and Development Command 41
Large-scale testing (Phase 3)Study completedNCT02207816
What this trial is testing

An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa

Who this might be right for
Malaria
GlaxoSmithKline 3,084
Early research (Phase 1)Ended earlyNCT04271306
What this trial is testing

Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.

Who this might be right for
Malaria,Falciparum
University of Oxford 34
Early research (Phase 1)Study completedNCT01988636
What this trial is testing

Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 296
Testing effectiveness (Phase 2)Study completedNCT02927145
What this trial is testing

A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate

Who this might be right for
Malaria
University of Oxford 88
Testing effectiveness (Phase 2)Study completedNCT04940130
What this trial is testing

PfSPZ Vaccine Trial in Malian Children

Who this might be right for
MalariaMalaria,Falciparum
Sanaria Inc. 290
Early research (Phase 1)UnknownNCT00424944
What this trial is testing

Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine

Who this might be right for
Malaria
African Malaria Network Trust 40
Testing effectiveness (Phase 2)Study completedNCT02925403
What this trial is testing

Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant

Who this might be right for
Malaria
University of Oxford 13
Testing effectiveness (Phase 2)Study completedNCT00197028
What this trial is testing

Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region

Who this might be right for
Malaria
GlaxoSmithKline 214
Early research (Phase 1)Study completedNCT00666380
What this trial is testing

Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya

Who this might be right for
Malaria
U.S. Army Medical Research and Development Command 26
Early research (Phase 1)WithdrawnNCT00977899
What this trial is testing

Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate Vaccine

Who this might be right for
MalariaMalaria VaccinesPlasmodium Falciparum Malaria
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Testing effectiveness (Phase 2)UnknownNCT00652275
What this trial is testing

Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine

Who this might be right for
Malaria
African Malaria Network Trust 378
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation